Article Details

P2X3 Receptor Antagonist Field Murkier as Bayer Abandons Program | BioSpace

Retrieved on: 2022-02-07 22:24:26

Tags for this article:

Click the tags to see associated articles and topics

P2X3 Receptor Antagonist Field Murkier as Bayer Abandons Program | BioSpace. View article details on HISWAI: https://www.biospace.com/article/bayer-abandons-evotec-compound-for-4-indications-including-chronic-cough/

Excerpt

After reviewing available data, Bayer decided to abandon its Phase II ... (EvopanOmics); advanced data analysis and prediction platform; EVOcells, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up